High-altitude adaptation in humans: from genomics to integrative physiology.
About 1.2 to 33% of high-altitude populations suffer from Monge's disease or chronic mountain sickness (CMS). Number of factors such as age, sex, and population of origin (older, male, Andean) contribute to the percentage reported from a variety of samples. It is estimated that there are around 83 million people who live at altitudes > 2500 m worldwide and are at risk for CMS. In this review, we focus on a human "experiment in nature" in various high-altitude locations in the world-namely, Andean, Tibetan, and Ethiopian populations that have lived under chronic hypoxia conditions for thousands of years. We discuss the adaptive as well as mal-adaptive changes at the genomic and physiological levels. Although different genes seem to be involved in adaptation in the three populations, we can observe convergence at genetic and signaling, as well as physiological levels. What is important is that we and others have shown that lessons learned from the genes mined at high altitude can be helpful in better understanding and treating diseases that occur at sea level. We discuss two such examples: EDNRB and SENP1 and their role in cardiac tolerance and in the polycythemic response, respectively.
['Azad|Priti|P|', 'Stobdan|Tsering|T|', 'Zhou|Dan|D|', 'Hartley|Iain|I|', 'Akbari|Ali|A|', 'Bafna|Vineet|V|', 'Haddad|Gabriel G|GG|']
D000222:Adaptation, Physiological D000531:Altitude D018703:Founder Effect D005828:Genetics, Population D023281:Genomics D006801:Humans D000860:Hypoxia
High-altitude adaptation Genomics Chronic mountain sickness Polycythemic response Cardiovascular response